These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
367 related articles for article (PubMed ID: 16763805)
1. Clinical value of apoptosis and angiogenesis factors in estimating the prognosis of hepatocellular carcinoma. Guo RP; Zhong C; Shi M; Zhang CQ; Wei W; Zhang YQ; Li JQ J Cancer Res Clin Oncol; 2006 Sep; 132(9):547-55. PubMed ID: 16763805 [TBL] [Abstract][Full Text] [Related]
2. [Expression and clinical significance of certain apoptosis and angiogenesis factors in hepatocellular carcinoma]. Guo RP; Zhong C; Shi M; Zhang CQ; Wei W; Zhang YQ; Li JQ Zhonghua Wai Ke Za Zhi; 2006 Dec; 44(23):1626-30. PubMed ID: 17359695 [TBL] [Abstract][Full Text] [Related]
3. [Expression and clinical significance of VEGF and MMP-9 in hepatocellular carcinoma]. Zhong C; Guo RP; Shi M; Wei W; Yu WS; Li JQ Ai Zheng; 2006 May; 25(5):599-603. PubMed ID: 16687082 [TBL] [Abstract][Full Text] [Related]
4. [Expressions of Survivin and vascular endothelial growth factor in hepatocellular carcinoma and their clinical significance]. Cui F; Chen B; Chen JZ; Huang YX; Luo RC Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):761-3. PubMed ID: 18504198 [TBL] [Abstract][Full Text] [Related]
5. [Expression and clinical impact of vascular endothelial growth factor and matrix metalloproteinase-2 in hepatocellular carcinoma]. Guo RP; Zhong C; Shi M; Zhang CQ; Wei W; Zhang YQ; Li JQ Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):285-8. PubMed ID: 16875630 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of VEGF is associated with positive p53 immunostaining in hepatocellular carcinoma (HCC) and adverse outcome of HCC patients. Tseng PL; Tai MH; Huang CC; Wang CC; Lin JW; Hung CH; Chen CH; Wang JH; Lu SN; Lee CM; Changchien CS; Hu TH J Surg Oncol; 2008 Oct; 98(5):349-57. PubMed ID: 18646041 [TBL] [Abstract][Full Text] [Related]
7. Serum and tissue vascular endothelial growth factor predicts prognosis in hepatocellular carcinoma patients after partial liver resection. Zhong C; Wei W; Su XK; Li HD; Xu FB; Guo RP Hepatogastroenterology; 2012; 59(113):93-7. PubMed ID: 22251524 [TBL] [Abstract][Full Text] [Related]
8. Relationship between survivin expression and recurrence, and prognosis in hepatocellular carcinoma. Ye CP; Qiu CZ; Huang ZX; Su QC; Zhuang W; Wu RL; Li XF World J Gastroenterol; 2007 Dec; 13(46):6264-8. PubMed ID: 18069771 [TBL] [Abstract][Full Text] [Related]
9. Expression and significance of new inhibitor of apoptosis protein survivin in hepatocellular carcinoma. Zhu H; Chen XP; Zhang WG; Luo SF; Zhang BX World J Gastroenterol; 2005 Jul; 11(25):3855-9. PubMed ID: 15991282 [TBL] [Abstract][Full Text] [Related]
10. Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma. Li YH; Hu CF; Shao Q; Huang MY; Hou JH; Xie D; Zeng YX; Shao JY J Transl Med; 2008 Jan; 6():1. PubMed ID: 18171482 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of AGGF1 is correlated with angiogenesis and poor prognosis of hepatocellular carcinoma. Wang W; Li GY; Zhu JY; Huang DB; Zhou HC; Zhong W; Ji CS Med Oncol; 2015 Apr; 32(4):131. PubMed ID: 25796501 [TBL] [Abstract][Full Text] [Related]
12. Expression of matrix metalloproteinase-9 in predicting prognosis of hepatocellular carcinoma after liver transplantation. Nart D; Yaman B; Yilmaz F; Zeytunlu M; Karasu Z; KiliƧ M Liver Transpl; 2010 May; 16(5):621-30. PubMed ID: 20440771 [TBL] [Abstract][Full Text] [Related]
13. TLR3 expression correlates with apoptosis, proliferation and angiogenesis in hepatocellular carcinoma and predicts prognosis. Yuan MM; Xu YY; Chen L; Li XY; Qin J; Shen Y BMC Cancer; 2015 Apr; 15():245. PubMed ID: 25884709 [TBL] [Abstract][Full Text] [Related]
14. Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma. Hu TH; Huang CC; Lin PR; Chang HW; Ger LP; Lin YW; Changchien CS; Lee CM; Tai MH Cancer; 2003 Apr; 97(8):1929-40. PubMed ID: 12673720 [TBL] [Abstract][Full Text] [Related]
15. Inducible nitric oxide synthase and survivin messenger RNA expression in hepatocellular carcinoma. Ikeguchi M; Ueta T; Yamane Y; Hirooka Y; Kaibara N Clin Cancer Res; 2002 Oct; 8(10):3131-6. PubMed ID: 12374680 [TBL] [Abstract][Full Text] [Related]
16. [Expression of vascular endothelial growth factor (VEGF) family members and prognosis after hepatic resection in HBV-related hepatocellular carcinoma]. Moon JI; Kim JM; Jung GO; Chun JM; Choi GS; Park JB; Kwon CH; Kim SJ; Jo JW Korean J Hepatol; 2008 Jun; 14(2):185-96. PubMed ID: 18617766 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma. Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803 [TBL] [Abstract][Full Text] [Related]
18. Expression of survivin mRNA associates with apoptosis, proliferation and histologically aggressive features in hepatocellular carcinoma. Morinaga S; Nakamura Y; Ishiwa N; Yoshikawa T; Noguchi Y; Yamamoto Y; Rino Y; Imada T; Takanashi Y; Akaike M; Sugimasa Y; Takemiya S Oncol Rep; 2004 Dec; 12(6):1189-94. PubMed ID: 15547736 [TBL] [Abstract][Full Text] [Related]
19. ASPM is a novel marker for vascular invasion, early recurrence, and poor prognosis of hepatocellular carcinoma. Lin SY; Pan HW; Liu SH; Jeng YM; Hu FC; Peng SY; Lai PL; Hsu HC Clin Cancer Res; 2008 Aug; 14(15):4814-20. PubMed ID: 18676753 [TBL] [Abstract][Full Text] [Related]
20. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma. Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]